 Amarin Corporation plc NASDAQ: AMRN shares are plunging after it said it would continue suspending 2022 revenue guidance and Q1 earnings came short of expectations. The update follows the ongoing global impact of COVID-19 and the uncertainty resulting from the impact of generic icosapent. 